ClinConnect ClinConnect Logo
Search / Trial NCT04193462

Relationship-Based Intervention for Post-Partum Depression

Launched by INTERDISCIPLINARY CENTER HERZLIYA · Dec 9, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Post Partum Depression Dyadic Psychotherapy Oxytocin

ClinConnect Summary

This clinical trial is studying a special therapy designed to help mothers who are experiencing Post-Partum Depression (PPD) during the first year after giving birth. The therapy focuses on improving the relationship between mothers and their babies, with the hope that both the mother's feelings of sadness and the bond they share will get better. Researchers believe that this treatment may also increase levels of a hormone called oxytocin, which is important for building connections and nurturing.

To participate in this study, mothers need to be diagnosed with PPD, either mild or severe, and must be between 3 to 8 months after giving birth to one baby. Unfortunately, mothers of twins, premature babies, or those with certain serious health issues for themselves or their babies cannot join. If eligible, participants can expect to engage in short-term therapy sessions that focus on improving their emotional well-being and their relationship with their child. This is an exciting opportunity to receive support and potentially feel better during a challenging time.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • women diagnosed with Post-Partum depression, major or minor, according to the Diagnostic and Statistical Manual of Mental Disorders, 5th version (DSM-5)
  • 3-8 months after birth of one baby
  • Exclusion Criteria:
  • Mothers of twins
  • Mothers of premature babies
  • Comorbidity of psychopathology, women who have severe personality disorder or other psychiatric diagnose, besides depression or anxiety
  • Women or babies who suffer from severe medical condition, such as developmental problems for the baby or disability.

About Interdisciplinary Center Herzliya

The Interdisciplinary Center Herzliya (IDC Herzliya) is a leading academic institution in Israel, renowned for its innovative research and education in various fields, including health sciences. As a clinical trial sponsor, IDC Herzliya is committed to advancing medical knowledge and improving patient outcomes through rigorous scientific investigation and interdisciplinary collaboration. The center leverages its diverse expertise to design and conduct high-quality clinical trials, ensuring adherence to ethical standards and regulatory requirements. With a focus on translating research findings into practical applications, IDC Herzliya plays a pivotal role in the development of novel therapies and interventions that address critical healthcare challenges.

Locations

Herzliya, , Israel

Patients applied

0 patients applied

Trial Officials

Moran Influs, Phd

Study Director

Interdisciplinary Center Herzliya, Israel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials